Pfizer-BioNtech COVID-19 Vaccine Guidance for Health Care Providers
The HTAC recommends the emergency use of the Pfizer-BioNTech COVID-19 Vaccine to prevent COVID-19 for persons aged 16 and older within identified priority groups. Pfizer-BioNTech COVID-19 Vaccine under emergency use The Food and Drug Administration (FDA) issues emergency use authorization (EUA) for unregistered vaccines and drugs during public health emergencies. This authorization expedites the availability continue reading : Pfizer-BioNtech COVID-19 Vaccine Guidance for Health Care Providers
HTAC recommends Pfizer-BioNTech COVID-19 Vaccine under emergency use for reducing COVID-19 risk in persons aged 16 and older
Pfizer-BioNTech COVID-19 vaccine under emergency use authorization (EUA) The Pfizer-BioNTech COVID-19 Vaccine under emergency use can reduce risk against COVID-19 for priority groups aged 16 and older, HTAC notes in a recent recommendation. Understanding mRNA vaccines Messenger RNA (mRNA) vaccines like the Pfizer-BioNTech COVID-19 Vaccine carry instructions for cells to make the “spike” protein unique continue reading : HTAC recommends Pfizer-BioNTech COVID-19 Vaccine under emergency use for reducing COVID-19 risk in persons aged 16 and older